T reg cell-based therapies: challenges and perspectives

Nat Rev Immunol. 2020 Mar;20(3):158-172. doi: 10.1038/s41577-019-0232-6. Epub 2019 Dec 6.

Abstract

Cellular therapies using regulatory T (Treg) cells are currently undergoing clinical trials for the treatment of autoimmune diseases, transplant rejection and graft-versus-host disease. In this Review, we discuss the biology of Treg cells and describe new efforts in Treg cell engineering to enhance specificity, stability, functional activity and delivery. Finally, we envision that the success of Treg cell therapy in autoimmunity and transplantation will encourage the clinical use of adoptive Treg cell therapy for non-immune diseases, such as neurological disorders and tissue repair.

Publication types

  • Review

MeSH terms

  • Animals
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / therapy
  • Cell- and Tissue-Based Therapy / methods*
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control
  • Humans
  • Immunotherapy, Adoptive / methods*
  • T-Lymphocytes, Regulatory / immunology*